Variant report
Variant | esv3477488 |
---|---|
Chromosome Location | chr7:129230993-129231919 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:129226672..129231038-chr7:129231303..129234307,4 | K562 | blood: | |
2 | chr7:129229009..129231952-chr7:129233633..129235471,2 | K562 | blood: | |
3 | chr7:129228702..129231746-chr7:129233208..129236163,3 | MCF-7 | breast: | |
4 | chr7:129226672..129231038-chr7:129231303..129234307,4 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575388978 | chr7:129231033-129231034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6975927 | chr7:129231044-129231045 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs562799821 | chr7:129231061-129231062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533572510 | chr7:129231075-129231076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551652079 | chr7:129231077-129231078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560432851 | chr7:129231138-129231139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373994115 | chr7:129231155-129231156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6467253 | chr7:129231175-129231176 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs191568375 | chr7:129231278-129231279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538454853 | chr7:129231281-129231282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537434600 | chr7:129231289-129231290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548833797 | chr7:129231300-129231301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7808752 | chr7:129231310-129231311 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs58246287 | chr7:129231341-129231342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs397957815 | chr7:129231354-129231355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571208892 | chr7:129231363-129231364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376572861 | chr7:129231385-129231386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554044309 | chr7:129231390-129231391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572247659 | chr7:129231404-129231405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536595513 | chr7:129231405-129231406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6976516 | chr7:129231409-129231410 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs553719067 | chr7:129231418-129231419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs207468602 | chr7:129231463-129231464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140025662 | chr7:129231467-129231468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539691968 | chr7:129231501-129231502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73464611 | chr7:129231588-129231589 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs563019076 | chr7:129231639-129231640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6467254 | chr7:129231657-129231658 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs371298169 | chr7:129231726-129231727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575966156 | chr7:129231752-129231753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545471540 | chr7:129231783-129231784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541604779 | chr7:129231810-129231811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560345186 | chr7:129231812-129231813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527878359 | chr7:129231825-129231826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183182059 | chr7:129231836-129231837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561206744 | chr7:129231861-129231862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149766474 | chr7:129231869-129231870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549483844 | chr7:129231889-129231890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531499661 | chr7:129231915-129231916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:129228200-129231800 | Weak transcription | Placenta | Placenta |
2 | chr7:129229800-129236000 | Enhancers | A549 | lung |
3 | chr7:129230200-129231800 | Weak transcription | Osteobl | bone |
4 | chr7:129231800-129232600 | Enhancers | HMEC | breast |
5 | chr7:129231800-129233800 | Enhancers | Placenta | Placenta |
6 | chr7:129231800-129237000 | Enhancers | Osteobl | bone |